Warning: The NCBI web site requires JavaScript to function. more...
Rituximab treatment in rheumatoid arthritis: how does it work?
Boumans MJ, Tak PP.
Arthritis Res Ther. 2009;11(6):134. Epub 2009 Nov 24.
Related citations
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response.
Nakou M, Katsikas G, Sidiropoulos P, Bertsias G, Papadimitraki E, Raptopoulou A, Koutala H, Papadaki HA, Kritikos H, Boumpas DT.
Arthritis Res Ther. 2009;11(4):R131. Epub 2009 Aug 28.
Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.
Rehnberg M, Amu S, Tarkowski A, Bokarewa MI, Brisslert M.
Arthritis Res Ther. 2009;11(4):R123. Epub 2009 Aug 17.
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.
Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP.
Arthritis Rheum. 2006 Aug;54(8):2377-86.
Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy.
Leandro MJ, Cooper N, Cambridge G, Ehrenstein MR, Edwards JC.
Rheumatology (Oxford). 2007 Jan;46(1):29-36. Epub 2006 May 30.
Good and bad memories following rituximab therapy.
St Clair EW.
Arthritis Rheum. 2010 Jan;62(1):1-5. No abstract available.
Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A.
Arthritis Rheum. 2010 Jan;62(1):64-74.
Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM.
Arthritis Rheum. 2007 Dec;56(12):3909-18.
Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment.
Vital EM, Dass S, Rawstron AC, Buch MH, Goëb V, Henshaw K, Ponchel F, Emery P.
Arthritis Rheum. 2010 May;62(5):1273-9.
Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis.
Dass S, Vital EM, Emery P.
Expert Opin Pharmacother. 2006 Dec;7(18):2559-70. Review.
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC.
Arthritis Rheum. 2006 Feb;54(2):613-20.
Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
Roll P, Dörner T, Tony HP.
Arthritis Rheum. 2008 Jun;58(6):1566-75.
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.
van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, Blom M, Risselada AP, de Haan A, Westra J, Kallenberg CG, Bijl M.
Arthritis Rheum. 2010 Jan;62(1):75-81.
Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y.
Arthritis Rheum. 2011 Dec;63(12):3692-701. doi: 10.1002/art.30599.
Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
Szodoray P, Alex P, Dandapani V, Nakken B, Pesina J, Kim X, Wallis GL, Wilson PC, Jonsson R, Centola M.
Scand J Immunol. 2004 Jul-Aug;60(1-2):209-18.
CD19: a promising B cell target for rheumatoid arthritis.
Tedder TF.
Nat Rev Rheumatol. 2009 Oct;5(10):572-7. Review.
Long term treatment of rheumatoid arthritis with rituximab.
Caporali R, Caprioli M, Bobbio-Pallavicini F, Bugatti S, Montecucco C.
Autoimmun Rev. 2009 Jun;8(7):591-4. Epub 2009 Feb 11.
What is the role of rituximab in the treatment of rheumatoid arthritis?
Atzeni F, Doria A, Turiel M, Sarzi-Puttini P.
Autoimmun Rev. 2007 Sep;6(8):553-8. Epub 2007 Mar 7. Review. Erratum in: Autoimmun Rev. 2010 Sep;9(11):793. Maurizio, Turiel [corrected to Turiel, Maurizio].
B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.
de la Torre I, Moura RA, Leandro MJ, Edwards J, Cambridge G.
Ann Rheum Dis. 2010 Dec;69(12):2181-8. Epub 2010 Jun 25. Erratum in: Ann Rheum Dis. 2011 Jul;70(7):1350.
Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
Teng YK, Levarht EW, Toes RE, Huizinga TW, van Laar JM.
Ann Rheum Dis. 2009 Jun;68(6):1011-6. Epub 2008 Jul 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on